Xiaohu Li Selected Research

porphine (porphin)

7/2022

Multimodal Imaging and Synergetic Chemodynamic/Photodynamic Therapy Achieved Using an NaGdF4 ,Yb,Er@ NaGdF4 ,Yb,Tm@NaYF4 @Fe-MOFs Nanocomposite.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohu Li Research Topics

Disease

12	Neoplasms (Cancer) 07/2022 - 11/2014
4	Glioma (Gliomas) 01/2022 - 11/2014
2	Hyperthermia 01/2022 - 01/2018
2	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
2	Adenocarcinoma of Lung 01/2021 - 01/2020
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2018 - 01/2015
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Fibrosis (Cirrhosis) 05/2021
1	Ureteral Obstruction 05/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Unstable Angina 01/2021
1	COVID-19 01/2021
1	Myocardial Infarction 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Schizophrenia (Dementia Praecox) 12/2020
1	Carcinoma (Carcinomatosis) 05/2019
1	Osteosarcoma (Osteogenic Sarcoma) 05/2019
1	Stomach Neoplasms (Stomach Cancer) 05/2019
1	Erythema 12/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Gout 01/2014
1	Urinary Calculi (Urinary Calculus) 04/2013

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	xylometazoline (stas)IBA 01/2021 - 01/2020
2	EnzymesIBA 01/2021 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2020
2	CopperIBA 01/2018 - 01/2015
2	Uric Acid (Urate)IBA 01/2014 - 04/2013
1	Contrast MediaIBA 07/2022
1	tetracarboxyphenylporphineIBA 07/2022
1	Metal-Organic FrameworksIBA 07/2022
1	NaGdF4IBA 07/2022
1	porphine (porphin)IBA 07/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	manganese dioxideIBA 01/2022
1	lobaplatinIBA 01/2022
1	CyclodextrinsIBA 01/2022
1	Dihydroxyphenylalanine (Dopa)IBA 01/2022
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	bromopyruvateIBA 05/2021
1	Protective AgentsIBA 05/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2021
1	PolymersIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Biological ProductsIBA 12/2020
1	ferric oxide (iron oxide)IBA 01/2020
1	FurinIBA 01/2020
1	Long Noncoding RNAIBA 05/2019
1	CateninsIBA 05/2019
1	Small Interfering RNA (siRNA)IBA 05/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2019
1	Prostaglandins AIBA 12/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	ferric ferrocyanide (Prussian blue)FDA Link 11/2014
1	IronIBA 11/2014
1	erucylphosphocholineIBA 11/2014
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 11/2014
1	StruviteIBA 04/2013
1	carboapatiteIBA 04/2013
1	Cystine (L-Cystine)IBA 04/2013
1	dihydrate dibasic calcium phosphate (brushite)IBA 04/2013
1	weddelliteIBA 04/2013
1	whewelliteIBA 04/2013

Therapy/Procedure

6	Therapeutics 07/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021
1	Photochemotherapy (Photodynamic Therapy) 07/2022
1	Precision Medicine 01/2022
1	Radiotherapy 01/2021
1	Photothermal Therapy 01/2020